Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2005
10/19/2005CN1223354C Chinese proprietary medicine for treating colitis
10/19/2005CN1223353C Yin-nourishing and heat-clearing, mental anxiety easing preparation
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956144 Mixture with flow control agents; antiulcer agents
10/18/2005US6956056 Method for providing a cathartic effect
10/18/2005US6956053 Mixtures of gastric juice secretion antagonist and proton pump inhibitors used for prophylaxis of eating disorders; cyclization
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956028 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005US6955806 For therapy of microbial infection in mammal
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2340054C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095445A1 Novel basic antibacterial peptide and utilization thereof
10/13/2005WO2005095412A1 Antiallergic agent
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095276A1 Method for producing spherical activated carbon
10/13/2005WO2005094888A1 Damaged tissue therapeutic agent and therapeutic method
10/13/2005WO2005094857A1 Decalepis hamiltonii for for hepatoprotective therapeutic use
10/13/2005WO2005094848A1 Agent for preventing or suppressing hepatopathy and functional food for preventing or suppressing hepatopathy
10/13/2005WO2005094845A1 Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease
10/13/2005WO2005094844A1 Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease
10/13/2005WO2005081613A3 Pharmaceutical compositions of peptides secreted by the venom glands of snakes
10/13/2005WO2004064717A3 Cop 1 for treatment of inflammatory bowel diseases
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228051 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228026 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227280 Proteases
10/13/2005US20050226946 Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and processing for producing the same
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226872 Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226822 Oral care products containing ovomucin
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005DE10393729T5 Verfahren zur Behandlung von Emesis A method of treating emesis
10/13/2005CA2562144A1 Process for manufacturing spherical activated carbon
10/13/2005CA2561731A1 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/13/2005CA2561730A1 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583531A1 Heteroaryl- substituted pyrrolo' 2, 3- b! pyridine derivatives as crf receptor antagonists
10/12/2005EP1583507A2 Magnesium salt of imidazole derivative
10/12/2005EP1511765A4 Par-2-activating peptide derivative and pharmaceutical composition using the same
10/12/2005EP1494659B1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005CN2732244Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite dispersible agent
10/12/2005CN2732243Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite capsule
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681802A Lansoprazole polymorphs and processes for preparation thereof
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681794A Preventive and/or therapeutic drugs for inflammatory intestinal diseases
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681519A Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681462A Nonwoven loop material and process and products relating thereto
10/12/2005CN1680549A Dendritic cell obtained by antigen pulsing
10/12/2005CN1680522A Healthy beer for treating astriction andp roduction thereof
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1679959A Liver targeted auxiliary material containing D-glactose and sterol and its use
10/12/2005CN1679941A Compound preparation consisting of taurine and medicines for hepatopathy and production thereof
10/12/2005CN1679940A Compound preparation of taurine and medicines for protecting liver and its making method
1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 1258